Predictors of treatment retention in enhanced and standard methadone maintenance treatment for HIV risk reduction

Predictors of treatment retention in enhanced and standard methadone maintenance treatment for HIV risk reduction
复制标题

DOI:
10.1177/002204269702700202
复制
发表时间:
1997-03-01
影响因子:
1.7
通讯作者:
Anglin, MD
Anglin, MD
中科院分区:
法学4区
文献类型:
--
作者:
Grella, CE;Wugalter, SE;Anglin, MD

文献摘要

被引文献

相似文献

生存分析战争用于确定 HIV 感染和/或传播高风险海洛因成瘾者从美沙酮维持治疗计划出院的预测因素,确定了一组一致的预测因素,与 90 天、12 个月、18 个月和 24 个月的治疗出院相关,摄入时 HIV 血清呈阳性、年龄较小、使用可卡因、每天饮酒以及在抑郁和人际关系问题测量中得分较高的个体处于出院风险较高; 接受强化美沙酮治疗,其中包括护理管理服务、团体参与、精神科服务、基于应急的强化措施和交通援助; 与较高保留概率相关的战争,特别是在前 90 天内; 这些发现可用于针对容易提前出院治疗的个人,并提供可能改善保留的辅助服务。 其中一些预测因素,特别是可卡因使用和心理问题,也与美沙酮中的艾滋病毒风险相关对于客户来说,增加美沙酮治疗的保留率不仅可以提高治疗效果,而且还可以满足限制艾滋病毒传播的公共卫生要求。
Survival analysis war used to determine the predictors of discharge from a methadone maintenance treatment program for heroin addicts at high-risk for HIV infection and/or transmission, A consistent set of predictors was identified that was associated with treatment discharge at 90 days, 12 months, 18 months, and 24 months, Individuals who, at intake, were HIV seropositive, were younger, used cocaine, drank alcohol daily, and scored high on measures of depression and interpersonal problems were at a higher risk for discharge, Receipt of enhanced methadone treatment, which included care management services, group participation, psychiatric services, contingency-based reinforcers, and transportation assistance, war associated with a higher probability of retention, particularly in the first 90 days, These findings can be used to target individuals who are vulnerable to early discharge from treatment and to provide adjunctive services that may improve retention, Several of these predictors, particularly cocaine use and psychological problems, have also been associated with HIV risk among methadone clients, increasing retention in methadone treatment will not only improve treatment efficacy but will also address the public health imperative to limit the transmission of HIV.